Felipe A Calvo1, Claudio V Sole2, Mauricio Cambeiro3, Angel Montero4, Alfredo Polo4, Carmen Gonzalez5, Miguel Cuervo6, Mikel San Julian7, Jose L Garcia-Sabrido8, Rafael Martinez-Monge3. 1. Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; School of Medicine, Complutense University, Madrid, Spain. 2. Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; School of Medicine, Complutense University, Madrid, Spain; Service of Radiation Oncology, Instituto de Radiomedicina, Santiago, Chile. Electronic address: cvsole@uc.cl. 3. Service of Radiation Oncology, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain. 4. Service of Radiation Oncology, Hospital Universitario Ramón y Cajal, Universidad de Alcala, Madrid, Spain. 5. School of Medicine, Complutense University, Madrid, Spain; Service of Radiation Oncology, Instituto de Radiomedicina, Santiago, Chile; Service of Radiation Oncology, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain; Service of Radiation Oncology, Hospital Universitario Ramón y Cajal, Universidad de Alcala, Madrid, Spain; Service of Radiation Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 6. Service of Orthopedics and Traumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 7. Service of Orthopedics and Traumatology, Clínica Universitaria, Universidad de Navarra, Pamplona, Spain. 8. School of Medicine, Complutense University, Madrid, Spain; Service of General Surgery III, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Abstract
BACKGROUND: A joint analysis of data from centers involved in the Spanish Cooperative Initiative for Intraoperative Electron Radiotherapy was performed to investigate long-term outcomes of locally recurrent soft tissue sarcoma (LR-STS) patients treated with a multidisciplinary approach. METHODS AND MATERIALS: Patients with a histologic diagnosis of LR-STS (extremity, 43%; trunk wall, 24%; retroperitoneum, 33%) and no distant metastases who underwent radical surgery and intraoperative electron radiation therapy (IOERT; median dose, 12.5 Gy) were considered eligible for participation in this study. In addition, 62% received external beam radiation therapy (EBRT; median dose, 50 Gy). RESULTS: From 1986 to 2012, a total of 103 patients from 3 Spanish expert IOERT institutions were analyzed. With a median follow-up of 57 months (range, 2-311 months), 5-year local control (LC) was 60%. The 5-year IORT in-field control, disease-free survival (DFS), and overall survival were 73%, 43%, and 52%, respectively. In the multivariate analysis, no EBRT to treat the LR-STS (P=.02) and microscopically involved margin resection status (P=.04) retained significance in relation to LC. With regard to IORT in-field control, only not delivering EBRT to the LR-STS retained significance in the multivariate analysis (P=.03). CONCLUSION: This joint analysis revealed that surgical margin and EBRT affect LC but that, given the high risk of distant metastases, DFS remains modest. Intensified local treatment needs to be further tested in the context of more efficient concurrent, neoadjuvant, and adjuvant systemic therapy.
BACKGROUND: A joint analysis of data from centers involved in the Spanish Cooperative Initiative for Intraoperative Electron Radiotherapy was performed to investigate long-term outcomes of locally recurrent soft tissue sarcoma (LR-STS) patients treated with a multidisciplinary approach. METHODS AND MATERIALS: Patients with a histologic diagnosis of LR-STS (extremity, 43%; trunk wall, 24%; retroperitoneum, 33%) and no distant metastases who underwent radical surgery and intraoperative electron radiation therapy (IOERT; median dose, 12.5 Gy) were considered eligible for participation in this study. In addition, 62% received external beam radiation therapy (EBRT; median dose, 50 Gy). RESULTS: From 1986 to 2012, a total of 103 patients from 3 Spanish expert IOERT institutions were analyzed. With a median follow-up of 57 months (range, 2-311 months), 5-year local control (LC) was 60%. The 5-year IORT in-field control, disease-free survival (DFS), and overall survival were 73%, 43%, and 52%, respectively. In the multivariate analysis, no EBRT to treat the LR-STS (P=.02) and microscopically involved margin resection status (P=.04) retained significance in relation to LC. With regard to IORT in-field control, only not delivering EBRT to the LR-STS retained significance in the multivariate analysis (P=.03). CONCLUSION: This joint analysis revealed that surgical margin and EBRT affect LC but that, given the high risk of distant metastases, DFS remains modest. Intensified local treatment needs to be further tested in the context of more efficient concurrent, neoadjuvant, and adjuvant systemic therapy.
Authors: Claudio V Sole; Felipe A Calvo; Carlos Ferrer; Javier Pascau; Hugo Marsiglia Journal: Strahlenther Onkol Date: 2014-06-14 Impact factor: 3.621
Authors: C V Sole; F A Calvo; M Cambeiro; A Polo; A Montero; R Hernanz; C Gonzalez; M Cuervo; D Perez; M S Julian; R Martinez-Monge Journal: Clin Transl Oncol Date: 2014-01-31 Impact factor: 3.405
Authors: Christopher L Tinkle; Vivian Weinberg; Steve E Braunstein; Rosanna Wustrack; Andrew Horvai; Thierry Jahan; Richard J O'Donnell; Alexander R Gottschalk Journal: Sarcoma Date: 2015-08-09